key: cord-0869914-mhxez733
authors: Wang, Ralph C.; Murphy, Charles E.; Kornblith, Aaron E.; Kurtz, Theodore; Kohn, Michael A.
title: Prevalence of SARS-Cov-2 Antibodies in Emergency Medicine Providers
date: 2021-01-11
journal: Ann Emerg Med
DOI: 10.1016/j.annemergmed.2021.01.010
sha: 3dd40e1361fa0f968d1f48b08a614fe25121a3e5
doc_id: 869914
cord_uid: mhxez733

nan

4/139 (2.9%, exact 95% CI = 0.8-7.2%). Three of the four seropositive participants were ED physicians who had a prior diagnosis of COVID-19 based on a prior positive PCR test and judged that they had a 76-100% likelihood of seropositivity. One seropositive participant, an ED nurse, had not received a prior diagnosis of COVID-19. This individual traveled at the beginning of February and subsequently developed fever and cough for 14 days, prior to the widespread availability of PCR testing.

A pediatric ED nurse reported traveling in February and subsequently experiencing symptoms of malaise, headache, loss of smell, and shortness of breath, leading to a positive PCR and positive antibody test in May 2020, who had a negative result in our study. Treating this individual as having had COVID-19 raises the prevalence of prior infection in our sample to 5/139 = 3.6% (exact 95% CI 1.2% -8.2%).

It is likely that seroprevalence among frontline providers varies with the cumulative incidence of COVID-19 in the communities they serve. The prevalence of prior infection in our 

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Waning Antibody Responses in Asymptomatic and Symptomatic SARS-CoV-2 Infection

Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients

Among Frontline Health Care Personnel in a Multistate Hospital Network -13 Academic Medical Centers

Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States